---
document_datetime: 2023-12-12 11:26:28
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/cufence-epar-all-authorised-presentations_en.pdf
document_name: cufence-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6970176
conversion_datetime: 2025-12-24 16:27:15.850791
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form   | Route of administration   | Immediate Packaging   | Pack size    |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|--------------|
| EU/1/19/1365/001 | Cufence           | 200 mg     | Capsule, hard         | Oral use                  | Bottle (glass)        | 100 capsules |
| EU/1/19/1365/002 | Cufence           | 100 mg     | Capsule, hard         | Oral use                  | Bottle (HDPE)         | 200 capsules |